Global Neuromodulation Devices and Implantable Infusion Pumps Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report is a detailed and comprehensive analysis for global Neuromodulation Devices and Implantable Infusion Pumps market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation Devices and Implantable Infusion Pumps
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales quantity, revenue, and global market share of Neuromodulation Devices and Implantable Infusion Pumps from 2021 to 2026.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices and Implantable Infusion Pumps.
Chapter 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report is a detailed and comprehensive analysis for global Neuromodulation Devices and Implantable Infusion Pumps market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2021-2032
Global Neuromodulation Devices and Implantable Infusion Pumps market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation Devices and Implantable Infusion Pumps
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagal Nerve Stimulation
- Gastric Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Stimulation
- Other
- Parkinson's Disease
- Epilepsy
- Pain
- Other
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical
- Synapse Biomedical
- Nevro Corporation
- Neuropace
- Cyberonics
- Autonomic Technologies
- Avery Biomedical
- Greatbatch Medical
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales quantity, revenue, and global market share of Neuromodulation Devices and Implantable Infusion Pumps from 2021 to 2026.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices and Implantable Infusion Pumps.
Chapter 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Vagal Nerve Stimulation
1.3.6 Gastric Stimulation
1.3.7 Transcranial Magnetic Stimulation
1.3.8 Transcutaneous Electrical Stimulation
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Parkinson's Disease
1.4.3 Epilepsy
1.4.4 Pain
1.4.5 Other
1.5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size & Forecast
1.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2021-2032)
1.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boston Scientific Corporation Recent Developments/Updates
2.3 St. Jude Medical
2.3.1 St. Jude Medical Details
2.3.2 St. Jude Medical Major Business
2.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 St. Jude Medical Recent Developments/Updates
2.4 Synapse Biomedical
2.4.1 Synapse Biomedical Details
2.4.2 Synapse Biomedical Major Business
2.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Synapse Biomedical Recent Developments/Updates
2.5 Nevro Corporation
2.5.1 Nevro Corporation Details
2.5.2 Nevro Corporation Major Business
2.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Nevro Corporation Recent Developments/Updates
2.6 Neuropace
2.6.1 Neuropace Details
2.6.2 Neuropace Major Business
2.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Neuropace Recent Developments/Updates
2.7 Cyberonics
2.7.1 Cyberonics Details
2.7.2 Cyberonics Major Business
2.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cyberonics Recent Developments/Updates
2.8 Autonomic Technologies
2.8.1 Autonomic Technologies Details
2.8.2 Autonomic Technologies Major Business
2.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Autonomic Technologies Recent Developments/Updates
2.9 Avery Biomedical
2.9.1 Avery Biomedical Details
2.9.2 Avery Biomedical Major Business
2.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Avery Biomedical Recent Developments/Updates
2.10 Greatbatch Medical
2.10.1 Greatbatch Medical Details
2.10.2 Greatbatch Medical Major Business
2.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Greatbatch Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY MANUFACTURER
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2021-2026)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2021-2026)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2025
3.4.3 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2025
3.5 Neuromodulation Devices and Implantable Infusion Pumps Market: Overall Company Footprint Analysis
3.5.1 Neuromodulation Devices and Implantable Infusion Pumps Market: Region Footprint
3.5.2 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
3.5.3 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2032)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2032)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2032)
4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2021-2032)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2021-2032)
6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
7.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
7.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
8.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
8.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
8.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
9.3.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
10.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
10.3 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
10.3.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
10.3.2 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
11.3.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
12.3 Neuromodulation Devices and Implantable Infusion Pumps Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Neuromodulation Devices and Implantable Infusion Pumps and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neuromodulation Devices and Implantable Infusion Pumps
13.3 Neuromodulation Devices and Implantable Infusion Pumps Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
14.3 Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Vagal Nerve Stimulation
1.3.6 Gastric Stimulation
1.3.7 Transcranial Magnetic Stimulation
1.3.8 Transcutaneous Electrical Stimulation
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Parkinson's Disease
1.4.3 Epilepsy
1.4.4 Pain
1.4.5 Other
1.5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size & Forecast
1.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2021-2032)
1.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boston Scientific Corporation Recent Developments/Updates
2.3 St. Jude Medical
2.3.1 St. Jude Medical Details
2.3.2 St. Jude Medical Major Business
2.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 St. Jude Medical Recent Developments/Updates
2.4 Synapse Biomedical
2.4.1 Synapse Biomedical Details
2.4.2 Synapse Biomedical Major Business
2.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Synapse Biomedical Recent Developments/Updates
2.5 Nevro Corporation
2.5.1 Nevro Corporation Details
2.5.2 Nevro Corporation Major Business
2.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Nevro Corporation Recent Developments/Updates
2.6 Neuropace
2.6.1 Neuropace Details
2.6.2 Neuropace Major Business
2.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Neuropace Recent Developments/Updates
2.7 Cyberonics
2.7.1 Cyberonics Details
2.7.2 Cyberonics Major Business
2.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cyberonics Recent Developments/Updates
2.8 Autonomic Technologies
2.8.1 Autonomic Technologies Details
2.8.2 Autonomic Technologies Major Business
2.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Autonomic Technologies Recent Developments/Updates
2.9 Avery Biomedical
2.9.1 Avery Biomedical Details
2.9.2 Avery Biomedical Major Business
2.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Avery Biomedical Recent Developments/Updates
2.10 Greatbatch Medical
2.10.1 Greatbatch Medical Details
2.10.2 Greatbatch Medical Major Business
2.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Greatbatch Medical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEUROMODULATION DEVICES AND IMPLANTABLE INFUSION PUMPS BY MANUFACTURER
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2021-2026)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2021-2026)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2025
3.4.3 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2025
3.5 Neuromodulation Devices and Implantable Infusion Pumps Market: Overall Company Footprint Analysis
3.5.1 Neuromodulation Devices and Implantable Infusion Pumps Market: Region Footprint
3.5.2 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
3.5.3 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2032)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2032)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2032)
4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2021-2032)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2021-2032)
6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
7.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
7.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
8.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
8.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
8.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
9.3.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
10.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
10.3 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
10.3.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
10.3.2 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
11.3.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
12.3 Neuromodulation Devices and Implantable Infusion Pumps Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Neuromodulation Devices and Implantable Infusion Pumps and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neuromodulation Devices and Implantable Infusion Pumps
13.3 Neuromodulation Devices and Implantable Infusion Pumps Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
14.3 Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 6. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Medtronic Recent Developments/Updates
Table 8. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Corporation Major Business
Table 10. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 11. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Boston Scientific Corporation Recent Developments/Updates
Table 13. St. Jude Medical Basic Information, Manufacturing Base and Competitors
Table 14. St. Jude Medical Major Business
Table 15. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 16. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. St. Jude Medical Recent Developments/Updates
Table 18. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 19. Synapse Biomedical Major Business
Table 20. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 21. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Synapse Biomedical Recent Developments/Updates
Table 23. Nevro Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Nevro Corporation Major Business
Table 25. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 26. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Nevro Corporation Recent Developments/Updates
Table 28. Neuropace Basic Information, Manufacturing Base and Competitors
Table 29. Neuropace Major Business
Table 30. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 31. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Neuropace Recent Developments/Updates
Table 33. Cyberonics Basic Information, Manufacturing Base and Competitors
Table 34. Cyberonics Major Business
Table 35. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 36. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Cyberonics Recent Developments/Updates
Table 38. Autonomic Technologies Basic Information, Manufacturing Base and Competitors
Table 39. Autonomic Technologies Major Business
Table 40. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 41. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Autonomic Technologies Recent Developments/Updates
Table 43. Avery Biomedical Basic Information, Manufacturing Base and Competitors
Table 44. Avery Biomedical Major Business
Table 45. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 46. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Avery Biomedical Recent Developments/Updates
Table 48. Greatbatch Medical Basic Information, Manufacturing Base and Competitors
Table 49. Greatbatch Medical Major Business
Table 50. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 51. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Greatbatch Medical Recent Developments/Updates
Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2021-2026) & (Unit)
Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 56. Market Position of Manufacturers in Neuromodulation Devices and Implantable Infusion Pumps, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site of Key Manufacturer
Table 58. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
Table 59. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
Table 60. Neuromodulation Devices and Implantable Infusion Pumps New Market Entrants and Barriers to Market Entry
Table 61. Neuromodulation Devices and Implantable Infusion Pumps Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2026) & (Unit)
Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2027-2032) & (Unit)
Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2026) & (USD/Unit)
Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2027-2032) & (USD/Unit)
Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2027-2032) & (USD/Unit)
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 77. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2026) & (USD/Unit)
Table 80. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2027-2032) & (USD/Unit)
Table 81. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 82. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 83. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 84. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 85. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 86. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 87. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 90. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 91. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 92. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 93. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 94. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 95. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 98. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 99. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 100. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 101. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2026) & (Unit)
Table 102. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2027-2032) & (Unit)
Table 103. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 106. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 107. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 108. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 109. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 110. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 111. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 114. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 115. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 116. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 117. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 118. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 119. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 122. Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Raw Materials
Table 123. Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
Table 124. Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 6. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Medtronic Recent Developments/Updates
Table 8. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Corporation Major Business
Table 10. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 11. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Boston Scientific Corporation Recent Developments/Updates
Table 13. St. Jude Medical Basic Information, Manufacturing Base and Competitors
Table 14. St. Jude Medical Major Business
Table 15. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 16. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. St. Jude Medical Recent Developments/Updates
Table 18. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 19. Synapse Biomedical Major Business
Table 20. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 21. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Synapse Biomedical Recent Developments/Updates
Table 23. Nevro Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Nevro Corporation Major Business
Table 25. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 26. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Nevro Corporation Recent Developments/Updates
Table 28. Neuropace Basic Information, Manufacturing Base and Competitors
Table 29. Neuropace Major Business
Table 30. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 31. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Neuropace Recent Developments/Updates
Table 33. Cyberonics Basic Information, Manufacturing Base and Competitors
Table 34. Cyberonics Major Business
Table 35. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 36. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Cyberonics Recent Developments/Updates
Table 38. Autonomic Technologies Basic Information, Manufacturing Base and Competitors
Table 39. Autonomic Technologies Major Business
Table 40. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 41. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Autonomic Technologies Recent Developments/Updates
Table 43. Avery Biomedical Basic Information, Manufacturing Base and Competitors
Table 44. Avery Biomedical Major Business
Table 45. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 46. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Avery Biomedical Recent Developments/Updates
Table 48. Greatbatch Medical Basic Information, Manufacturing Base and Competitors
Table 49. Greatbatch Medical Major Business
Table 50. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 51. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Greatbatch Medical Recent Developments/Updates
Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2021-2026) & (Unit)
Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 56. Market Position of Manufacturers in Neuromodulation Devices and Implantable Infusion Pumps, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site of Key Manufacturer
Table 58. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
Table 59. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
Table 60. Neuromodulation Devices and Implantable Infusion Pumps New Market Entrants and Barriers to Market Entry
Table 61. Neuromodulation Devices and Implantable Infusion Pumps Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2026) & (Unit)
Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2027-2032) & (Unit)
Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2021-2026) & (USD/Unit)
Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2027-2032) & (USD/Unit)
Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2027-2032) & (USD/Unit)
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 77. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2026) & (USD/Unit)
Table 80. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2027-2032) & (USD/Unit)
Table 81. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 82. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 83. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 84. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 85. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 86. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 87. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 90. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 91. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 92. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 93. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 94. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 95. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 98. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 99. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 100. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 101. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2021-2026) & (Unit)
Table 102. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2027-2032) & (Unit)
Table 103. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 106. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 107. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 108. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 109. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 110. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 111. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2021-2026) & (Unit)
Table 114. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2027-2032) & (Unit)
Table 115. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2021-2026) & (Unit)
Table 116. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2027-2032) & (Unit)
Table 117. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2021-2026) & (Unit)
Table 118. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2027-2032) & (Unit)
Table 119. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 122. Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Raw Materials
Table 123. Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
Table 124. Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
LIST OF FIGURES
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Picture
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type in 2025
Figure 4. Spinal Cord Stimulation Examples
Figure 5. Deep Brain Stimulation Examples
Figure 6. Sacral Nerve Stimulation Examples
Figure 7. Vagal Nerve Stimulation Examples
Figure 8. Gastric Stimulation Examples
Figure 9. Transcranial Magnetic Stimulation Examples
Figure 10. Transcutaneous Electrical Stimulation Examples
Figure 11. Other Examples
Figure 12. Transcutaneous Electrical Stimulation Examples
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2025
Figure 15. Parkinson's Disease Examples
Figure 16. Epilepsy Examples
Figure 17. Pain Examples
Figure 18. Other Examples
Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2021-2032) & (Unit)
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Price (2021-2032) & (USD/Unit)
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2025
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2021-2032)
Figure 30. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Type (2021-2032)
Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032) & (USD/Unit)
Figure 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032)
Figure 40. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032) & (USD/Unit)
Figure 41. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 53. France Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2021-2032)
Figure 61. China Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 64. India Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 81. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
Figure 82. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
Figure 83. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2025
Figure 86. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 87. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Picture
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type in 2025
Figure 4. Spinal Cord Stimulation Examples
Figure 5. Deep Brain Stimulation Examples
Figure 6. Sacral Nerve Stimulation Examples
Figure 7. Vagal Nerve Stimulation Examples
Figure 8. Gastric Stimulation Examples
Figure 9. Transcranial Magnetic Stimulation Examples
Figure 10. Transcutaneous Electrical Stimulation Examples
Figure 11. Other Examples
Figure 12. Transcutaneous Electrical Stimulation Examples
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2025
Figure 15. Parkinson's Disease Examples
Figure 16. Epilepsy Examples
Figure 17. Pain Examples
Figure 18. Other Examples
Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2021-2032) & (Unit)
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Price (2021-2032) & (USD/Unit)
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2025
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2021-2032)
Figure 30. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Type (2021-2032)
Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2021-2032) & (USD/Unit)
Figure 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032)
Figure 40. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2021-2032) & (USD/Unit)
Figure 41. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 53. France Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2021-2032)
Figure 61. China Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 64. India Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2021-2032) & (USD Million)
Figure 81. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
Figure 82. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
Figure 83. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2025
Figure 86. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 87. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
